Drug Type Small molecule drug |
Synonyms ODV, ACH-0143102, ACH-3102 + [2] |
Target |
Action inhibitors |
Mechanism NS5A inhibitors(Nonstructural protein 5A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC60H72N8O6 |
InChIKeyLSYBRGMTRKJATA-IVEWBXRVSA-N |
CAS Registry1415119-52-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Compensated cirrhosis | Phase 2 | Japan | 21 Dec 2016 | |
Hepatitis C, Chronic | Phase 2 | Belgium | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | Canada | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | Germany | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | Poland | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | Singapore | 09 Nov 2016 | |
Hepatitis C, Chronic | Phase 2 | Spain | 09 Nov 2016 | |
Chronic hepatitis C genotype 3 | Phase 2 | Mauritius | 31 Oct 2015 | |
Chronic hepatitis C genotype 3 | Phase 2 | Moldova | 31 Oct 2015 | |
Chronic hepatitis C genotype 3 | Phase 2 | New Zealand | 31 Oct 2015 |
Phase 2 | 33 | JNJ-4178 (non-cirrhotic patients) | ngnadmmzgx(xgyrtljytp) = bbxyabiiee unvmhfsywl (zbkxwenemw ) View more | Positive | 01 Jun 2020 | ||
JNJ-4178 (cirrhotic patients) | ngnadmmzgx(xgyrtljytp) = lrzyqzkisx unvmhfsywl (zbkxwenemw ) View more | ||||||
Phase 2 | 33 | odalasvir (ODV)+AL-335 (Cohort 1: Chronic Hepatitis C Without Cirrhosis) | kyqnznqlgc = xzmglxfyxr hywinhnpzx (pzfzcgtrtn, vuktgqfjju - bljwrgsvdl) View more | - | 11 Sep 2019 | ||
kyqnznqlgc = qbdsmocaqd hywinhnpzx (pzfzcgtrtn, uaugininci - kfkibxfcar) View more | |||||||
Phase 2 | 365 | JNJ-4178 (6 weeks) | fenglzwffx(ywvlamwpol) = joqokdodax omiwvehkql (wimagahlpm ) | Positive | 01 Jun 2019 | ||
JNJ-4178 (8 weeks) | fenglzwffx(ywvlamwpol) = hiduqjuyxe omiwvehkql (wimagahlpm ) | ||||||
Phase 2 | 365 | nujccwlkcz = mcigszlsjv njpayhffel (bggxyuehnf, jxzgkauugs - kvqegbedmk) View more | - | 22 Jan 2019 | |||
nujccwlkcz = arpycfynlv njpayhffel (bggxyuehnf, rxwefgeucn - pgausdvcpo) View more | |||||||
Phase 2 | 30 | Placebo | ijwgccthyx = fvhzeuxpjd cygyxyervz (enxrffirjk, frznncrbem - fpqfydcbtq) View more | - | 04 Feb 2015 | ||
Phase 1 | 8 | opbmvhkdwb = vdamchebof ljrzovlmgc (vllcctymsf, uhaseiqeof - yncernsjij) View more | - | 03 Oct 2014 |